Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (451-460 of 517) with videos related to

Pageof 52
Sort By:
The American Journal of Psychiatry|April 3, 2010
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorderRoy H Perlis, Jordan W Smoller, Jayalakshmi Mysore, et al.
Journal of Affective Disorders|February 22, 2023
Psychometric evaluation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR<sub>9</sub>) (a measure of suicidal risk) in adolescent psychiatric outpatients in the Texas Youth Depression and Suicide Research Network (TX-YDSRN)Karabi Nandy, A John Rush, Holli Slater, et al.
Translational Psychiatry|July 6, 2019
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatientsSudeepa Bhattacharyya, Ahmed T Ahmed, Matthias Arnold, et al.
Archives of General Psychiatry|July 9, 2004
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm ProjectMadhukar H Trivedi, A John Rush, M Lynn Crismon, et al.
Schizophrenia Bulletin|January 6, 2005
The Texas medication algorithm project: clinical results for schizophreniaAlexander L Miller, M Lynn Crismon, A John Rush, et al.
The Journal of Clinical Psychiatry|February 19, 2008
The efficacy of acute electroconvulsive therapy in atypical depressionMustafa M Husain, Shawn M McClintock, A John Rush, et al.
Blood|October 11, 2008
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCLFrancesco E Boccalatte, Claudia Voena, Chiara Riganti, et al.
The Journal of Clinical Psychiatry|May 4, 2004
Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) reportMustafa M Husain, A John Rush, Max Fink, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2003
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood traumaCharles B Nemeroff, Christine M Heim, Michael E Thase, et al.
Biological Psychiatry|October 4, 2002
Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disordersEllen Frank, A John Rush, Mary Blehar, et al.
Pageof 52

Showing results (451-460 of 517) with videos related to

Sort By:
Pageof 52
The American Journal of Psychiatry|April 3, 2010
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorderRoy H Perlis, Jordan W Smoller, Jayalakshmi Mysore, et al.
Journal of Affective Disorders|February 22, 2023
Psychometric evaluation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR<sub>9</sub>) (a measure of suicidal risk) in adolescent psychiatric outpatients in the Texas Youth Depression and Suicide Research Network (TX-YDSRN)Karabi Nandy, A John Rush, Holli Slater, et al.
Translational Psychiatry|July 6, 2019
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatientsSudeepa Bhattacharyya, Ahmed T Ahmed, Matthias Arnold, et al.
Archives of General Psychiatry|July 9, 2004
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm ProjectMadhukar H Trivedi, A John Rush, M Lynn Crismon, et al.
Schizophrenia Bulletin|January 6, 2005
The Texas medication algorithm project: clinical results for schizophreniaAlexander L Miller, M Lynn Crismon, A John Rush, et al.
The Journal of Clinical Psychiatry|February 19, 2008
The efficacy of acute electroconvulsive therapy in atypical depressionMustafa M Husain, Shawn M McClintock, A John Rush, et al.
Blood|October 11, 2008
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCLFrancesco E Boccalatte, Claudia Voena, Chiara Riganti, et al.
The Journal of Clinical Psychiatry|May 4, 2004
Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) reportMustafa M Husain, A John Rush, Max Fink, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2003
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood traumaCharles B Nemeroff, Christine M Heim, Michael E Thase, et al.
Biological Psychiatry|October 4, 2002
Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disordersEllen Frank, A John Rush, Mary Blehar, et al.
Pageof 52